Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,477.16
(
-1.74%
)
US TECH 100
23,016.00
(
-2.11%
)
Dow Jones
45,960.11
(
-1.01%
)
Brent Oil
101.60
(
2.86%
)
Bitcoin
68,977.41
(
-3.26%
)
News Focus
News Focus
Post# of 257295
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Biowatch

Send PM Follow Ignore
Followers 63
Posts 6886
Boards Moderated 1
Alias Born 10/18/2003

Biowatch

Member Level

Re: DewDiligence post# 11336

Thursday, 05/19/2005 8:15:12 AM

Thursday, May 19, 2005 8:15:12 AM

Post# of 257295
>>The oncologist conference also saw data presented questioning the value of lengthy drug trials.<<

Do you happen to know which session this was? Or a link?

From post # 11340

>>Even now, says Nicholas Vogelzang, director of the Nevada Cancer Institute, there is a real "paucity" of data for Erbitux, compared with that available for other targeted agents, such as Avastin. <<

Lets hear it for IMCL management!
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today